DE60227058D1 - - Google Patents

Info

Publication number
DE60227058D1
DE60227058D1 DE60227058T DE60227058T DE60227058D1 DE 60227058 D1 DE60227058 D1 DE 60227058D1 DE 60227058 T DE60227058 T DE 60227058T DE 60227058 T DE60227058 T DE 60227058T DE 60227058 D1 DE60227058 D1 DE 60227058D1
Authority
DE
Germany
Prior art keywords
frk
tyrosine kinase
relates
inhibitor
type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60227058T
Other languages
English (en)
Inventor
Michael Welsh
Cecilia Anneren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Innoventus Project AB
Original Assignee
Innoventus Project AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innoventus Project AB filed Critical Innoventus Project AB
Application granted granted Critical
Publication of DE60227058D1 publication Critical patent/DE60227058D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
DE60227058T 2001-04-06 2002-04-05 Expired - Fee Related DE60227058D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0101230A SE0101230L (sv) 2001-04-06 2001-04-06 Ny användning av en tyrosinkinasinhibitor
PCT/SE2002/000682 WO2002080894A1 (en) 2001-04-06 2002-04-05 Novel use of tyrosine kinase inhibitor

Publications (1)

Publication Number Publication Date
DE60227058D1 true DE60227058D1 (de) 2008-07-24

Family

ID=20283697

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60227058T Expired - Fee Related DE60227058D1 (de) 2001-04-06 2002-04-05

Country Status (7)

Country Link
US (1) US20040171563A1 (de)
EP (1) EP1372621B1 (de)
AT (1) ATE397921T1 (de)
DE (1) DE60227058D1 (de)
DK (1) DK1372621T3 (de)
SE (1) SE0101230L (de)
WO (1) WO2002080894A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060094682A1 (en) * 2004-10-29 2006-05-04 Odyssey Thera, Inc. Kinase inhibitors for the treatment of diabetes and obesity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177401B1 (en) * 1992-11-13 2001-01-23 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis
US5880141A (en) * 1995-06-07 1999-03-09 Sugen, Inc. Benzylidene-Z-indoline compounds for the treatment of disease
GB9718913D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Substituted oxindole derivatives
GB9721437D0 (en) * 1997-10-10 1997-12-10 Glaxo Group Ltd Heteroaromatic compounds and their use in medicine
CA2459879A1 (en) * 2001-09-10 2003-03-20 Sugen, Inc. 3-(4,5,6,7-tetrahydroindol-2-ylmethylidiene)-2-indolinone derivatives as kinase inhibitors

Also Published As

Publication number Publication date
US20040171563A1 (en) 2004-09-02
SE0101230L (sv) 2002-10-07
EP1372621B1 (de) 2008-06-11
EP1372621A1 (de) 2004-01-02
SE0101230D0 (sv) 2001-04-06
WO2002080894A1 (en) 2002-10-17
ATE397921T1 (de) 2008-07-15
DK1372621T3 (da) 2008-10-20

Similar Documents

Publication Publication Date Title
MY152172A (en) Therapeutic agent for diabetes
PT1928499E (pt) Utilização de um inibidor da dpp-iv para reduzir eventos hipoglicémicos
TNSN06315A1 (en) Sulfonamide-thiazolpyridine derivatives as glucokinase activators useful the treatment of type 2 diabetes
TW200745037A (en) Organic compounds
UA88257C2 (ru) ПРИМЕНЕНИЕ ИНГИБИТОРА ПРОТЕИНКИНАЗЫ С-α ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ ПОЧЕК, КОТОРЫЕ ПРИВОДЯТ К ПРОТЕИНУРИИ, И ДИАБЕТИЧЕСКИМ РЕТИНОПАТИИ, НЕВРОПАТИИ ИЛИ НЕФРОПАТИИ
YU34404A (sh) N-supstituisani derivati pirolidina kao inhibitori dipeptidil-peptidaze iv
WO2009023718A3 (en) Novel activators of glucokinase
HUP0402403A2 (hu) Cukorbetegség-ellenes hatású dipeptilpeptidáz IV (DP-IV) inhibitorok ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
MY127961A (en) Beta-amino heterocyclic dipetidyl peptidase inhibitors for the treament or prevention of diabetes
NZ599298A (en) Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin
EP1671649A4 (de) Mittel zur behandlung von diabetes
IS7753A (is) Beta-amínó heterósýklískir dípeptidýl peptíðasa hindrar til meðhöndlunar á, eða til að fyrirbyggja,sykursýki
EP1385508A4 (de) Dipeptidylpeptidase-hemmer für die behandlung oder prävention von diabetes
MXPA03011083A (es) Compuestos de sulfonamida sustituida, procedimiento para su preparacion, y su uso como medicamento para el tratamiento de trastornos del sistema nervioso central. obesidad y diabetes tipo ii.
WO2006044556A3 (en) Dual inhibitors of lipoxygenase for treating diabetes
IN2015DN01132A (de)
EP1490335A4 (de) Heterocyclische beta-aminoverbindungen als inhibitoren der dipeptidylpeptidase zur behandlung bzw. prävention von diabetes
WO2010029089A3 (en) Combination therapy for the treatment of diabetes and related conditions
MX2007005590A (es) Compuestos del inhibidor glicogeno fosforilasa y sus composiciones farmaceuticas.
MXPA04001500A (es) Compuestos que tienen un efecto sobre la glucocinasa.
MY135222A (en) Substituted phenylacetamides and their use as glucokinase activators
HK1112239A1 (de)
WO2006031980A3 (en) Treatment for cancer-related fatigue
HUP0401998A2 (hu) PDE9 inhibitorok alkalmazása olyan gyógyszer előállítására, amellyel inzulin-rezisztencia szindróma és 2-es típusú diabétesz kezelhető
WO2004050115A3 (en) Combination treatment using exendin-4 and thiazolidinediones

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee